Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paroxetine: a review.

M Bourin1, P Chue, Y Guillon

  • 1Neurobiology of Anxiety and Depression, Faculty of Medicine, BP 53508, F-44035 Nantes Cedex 1, France. mbourin@sante.univ-nantes.fr

CNS Drug Reviews
|June 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined effect of divergent selection for breast muscle ultimate pH and dietary amino acids on chicken performance, physical activity and meat quality.

Animal : an international journal of animal bioscience·2016
Same author

5-HT2C receptors in psychiatric disorders: A review.

Progress in neuro-psychopharmacology & biological psychiatry·2016
Same author

Is rehospitalization a measure of the efficacy of neuroleptics in the treatment of schizophrenia?

International journal of psychiatry in clinical practice·2014
Same author

The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia.

Current medical research and opinion·2013
Same author

Sex- and tissue-specific expression of "similar to nothepsin" and cathepsin D in relation to egg yolk formation in Gallus gallus.

Poultry science·2012
Same author

Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteers.

Journal of psychopharmacology (Oxford, England)·2012
Same journal

Glial Cells in Aging and Neurodegeneration. A Satellite Symposium to the 28<sup>th</sup> Annual Meeting of the Society for Neuroscience. Los Angeles, CA, November 7, 1998.

CNS drug reviews·2017
Same journal

Neuron-Glial Interactions. The Sixth Annual University of Southern California Neuroscience Symposium, Los Angeles, November 6, 1998.

CNS drug reviews·2017
Same journal

The Pharmacology and Mechanism of Action of Zolpidem.

CNS drug reviews·2017
Same journal

Zonisamide: Pharmacology and Clinical Efficacy in Epilepsy.

CNS drug reviews·2017
Same journal

1998 Annual Meeting of the Society for Neuroscience: New Drugs Affecting the Central Nervous System. Los Angeles, California, November 7-12, 1998.

CNS drug reviews·2017
Same journal

Application of Gene Knockout Technique to Alcohol Research. Satellite Symposium to the 28<sup>th</sup> Annual Meeting of the Society for Neuroscience. Los Angeles, CA, November 7, 1998.

CNS drug reviews·2017
See all related articles

Paroxetine is a highly selective serotonin reuptake inhibitor (SSRI) effective for depression and anxiety disorders. It offers a favorable side effect profile compared to older antidepressants, with rare serious adverse events.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Paroxetine is a selective serotonin reuptake inhibitor (SSRI) used for depression, OCD, panic disorder, and social phobia.
  • It is also utilized for generalized anxiety disorder, PTSD, premenstrual dysphoric disorder, and chronic headache.
  • Paroxetine exhibits potent serotonin reuptake inhibition with high selectivity over norepinephrine reuptake.

Purpose of the Study:

  • To review the pharmacological properties and clinical applications of paroxetine.
  • To compare its efficacy and side effect profile with other antidepressants, particularly TCAs.
  • To summarize its pharmacokinetic and pharmacodynamic characteristics.

Main Methods:

  • Review of existing literature on paroxetine's mechanism of action, clinical trials, and pharmacokinetic studies.

Related Experiment Videos

  • Comparative analysis of paroxetine's receptor binding profile and side effect profile against other SSRIs and TCAs.
  • Examination of paroxetine's metabolism, absorption, and elimination pathways.

    • Main Results:

    • Paroxetine demonstrates superior potency and selectivity for serotonin reuptake inhibition among SSRIs.
    • It has a lower propensity for central and autonomic side effects compared to TCAs due to minimal affinity for other neurotransmitter systems.
    • Pharmacokinetics show wide inter-individual variation, with slower elimination in the elderly and those with renal/hepatic impairment; however, it is well-tolerated even in overdose.

    Conclusions:

    • Paroxetine is a well-tolerated and effective SSRI for treating various depressive and anxiety disorders across different age groups.
    • Its distinct pharmacological profile contributes to a favorable safety and tolerability compared to tricyclic antidepressants.
    • Understanding its pharmacokinetics is crucial for optimizing patient treatment, especially in specific populations.